A Multicenter Study in Mexico Finds Acinetobacter baumannii Clinical Isolates Belonging to Clonal Complexes 636B (113B) and 92B Harboring OXA-72, OXA-239, and OXA-469

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2587-8. doi: 10.1128/AAC.02042-15. Print 2016 Apr.
No abstract available

Publication types

  • Letter
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acinetobacter Infections / drug therapy
  • Acinetobacter Infections / epidemiology
  • Acinetobacter Infections / microbiology
  • Acinetobacter baumannii / classification
  • Acinetobacter baumannii / drug effects
  • Acinetobacter baumannii / genetics*
  • Acinetobacter baumannii / isolation & purification
  • Anti-Bacterial Agents / pharmacology
  • Bacterial Proteins / genetics*
  • Bacterial Proteins / metabolism
  • Carbapenems / pharmacology
  • Clone Cells
  • Electrophoresis, Gel, Pulsed-Field
  • Gene Expression
  • Hospitals
  • Humans
  • Isoenzymes / genetics
  • Isoenzymes / metabolism
  • Mexico / epidemiology
  • Microbial Sensitivity Tests
  • Public Health Surveillance
  • beta-Lactam Resistance / genetics*
  • beta-Lactamases / genetics*
  • beta-Lactamases / metabolism

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Carbapenems
  • Isoenzymes
  • OXA-72 carbapenemase, Acinetobacter baumannii
  • beta-Lactamases

Grants and funding

This work was funded by Consejo Nacional de Ciencia y Tecnología (CONACYT) through SEPCONACYT grant numbers 169867, 136339, 130224, and 205707. A.M.G.-V. was a Ph.D. fellow from CONACYT.